Brief: Organogenesis Q1 Revenue USD 110 Million
09/05/2024 21:05
May 09 (Reuters) - Organogenesis Q1 adjusted net income USD -1.4 million. * Q1 operating income USD -3.9 million * Q1 net income USD -2.1 million * Q1 adjusted EBITDA USD 2.6 million * outlook FY EBITDA USD 5.8-25 million * outlook FY adjusted EBITDA USD 15.8-35 million
Recent news on Organogenesis Holdings
See all newsBrief: Organogenesis Announces Publication Of Peer-Reviewed Prepare Trial Results
Organogenesis Holdings Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Organogenesis Q2 Net Product Revenue USD 42.8 Million
Organogenesis Holdings Inc. expected to post a loss of 35 cents a share - Earnings Preview
Brief: Organogenesis Announces Publication Of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit Of Affinity™ In The Most Challenging And Complex Venous Leg Ulcers